Web conference on Merrimack announcement
Ipsen announced on January 9, 2017 that it has entered into a definitive agreement to acquire global oncology assets from Merrimack Pharmaceuticals, including its key marketed product ONIVYDE®.
Conference call & web conference:
- Date: 9 January, 2017
- Time: 2:30pm CET/ 8:30am EST
Replay available for seven days. Click here or dial:
- France and continental Europe +33 (0)1 7099 3529
- UK +44 (0)20 7031 4064
- United States +1 954 334 0342
- Conference ID: 961094